Literatur
Dimopoulos MA et al. N Engl J Med. 2018;378(25):2399-410
Treon SP et al. N Engl J Med. 2015;372(15):1430-40
Hiller E. InFo Häm + Onk. 2018;21(5):14-6
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hiller, E. Acalabrutinib in der Behandlung des Morbus Waldenström. InFo Hämatol Onkol 23, 24–25 (2020). https://doi.org/10.1007/s15004-020-8097-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15004-020-8097-1